1016 s0140 67360107103 3 5 dunlop sp coleman ns

: 2061-2068 [PMID: 11755632 DOI: 10.1016/
S0140-6736(01)07103-3]
5 Dunlop SP , Coleman NS, Blackshaw E, Perkins AC, Singh
G, Marsden CA, Spiller RC. Abnormalities of 5-hydroxy -
tryptamine metabolism in irritable bowel syndrome. Clin
Gastroenterol Hepatol 2005; 3 : 349-357 [PMID: 15822040 DOI:
10.1016/S1542-3565(04)00726-8]
6 Coates MD , Mahoney CR, Linden DR, Sampson JE, Chen J,
Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe
GM, Moses PL. Molecular defects in mucosal serotonin
content and decreased serotonin reuptake transporter in
ulcerative colitis and irritable bowel syndrome. Gastroenter-
ology 2004; 126 : 1657-1664 [PMID: 15188158 DOI: 10.1053/
j.gastro.2004.03.013]
7 Drossman DA , Camilleri M, Mayer EA, Whitehead WE.
AGA technical review on irritable bowel syndrome. Gas-
troenterology 2002; 123 : 2108-2131 [PMID: 12454866 DOI:
10.1053/gast.2002.37095]
8 Van Oudenhove L , Vandenberghe J, Demyttenaere K, Tack
J. Psychosocial factors, psychiatric illness and functional
gastrointestinal disorders: a historical perspective. Digestion
2010; 82 : 201-210 [PMID: 20588034 DOI: 10.1159/000269822]
9 Whitehead WE , Burnett CK, Cook EW, Taub E. Impact of
irritable bowel syndrome on quality of life. Dig Dis Sci 1996;
41 : 2248-2253 [PMID: 8943980 DOI: 10.1007/BF02071408]
10 Drossman DA , Li Z, Andruzzi E, Temple RD, Talley NJ,
Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P,
Corazziari E. U.S. householder survey of functional gastroin -
testinal disorders. Prevalence, sociodemography, and health
impact. Dig Dis Sci 1993; 38 : 1569-1580 [PMID: 8359066 DOI:
10.1007/BF01303162]
11 World Gastroenterology Organization . Irritable bowel
syndrome: a global perspective. World Gastroenterology
Organisation Global Guideline 2009. Available from: URL:
WORLD
GASTRO.pdf
12 Hammer J , Eslick GD, Howell SC, Altiparmak E, Talley
NJ. Diagnostic yield of alarm features in irritable bowel
syndrome and functional dyspepsia. Gut 2004; 53 : 666-672
[PMID: 15082584 DOI: 10.1136/gut.2003.021857]
13 Drossman DA , Corazziari E, Talley NJ, Thompson WG,
Whitehead WE. Rome II: The Functional Gastrointestinal
Disorders: Diagnosis, Pathophysiology, and Treatment: A
Multinational Consensus. 2nd ed. McLean, VA: Degnon As-
sociates, 2000
14 Talley NJ , Spiller R. Irritable bowel syndrome: a little under -
stood organic bowel disease? Lancet 2002; 360 : 555-564 [PMID:
12241674 DOI: 10.1016/S0140-6736(02)09712-X]
15 Holten KB , Wetherington A, Bankston L. Diagnosing the pa-
tient with abdominal pain and altered bowel habits: is it irri-
table bowel syndrome? Am Fam Physician 2003; 67 : 2157-2162
[PMID: 12776965]
16 Boyce PM , Talley NJ, Burke C, Koloski NA. Epidemiology
of the functional gastrointestinal disorders diagnosed ac -
cording to Rome II criteria: an Australian population-based
study. Intern Med J 2006;
36
: 28-36 [PMID: 16409310 DOI:
10.1111/j.1445-5994.2006.01006.x]
17 Locke GR , Zinsmeister AR, Fett SL, Melton LJ, Talley NJ.
Overlap of gastrointestinal symptom complexes in a US
community. Neurogastroenterol Motil 2005; 17 : 29-34 [PMID:
15670261 DOI: 10.1111/j.1365-2982.2004.00581.x]
18 Gwee KA . Irritable bowel syndrome in developing coun -
tries--a disorder of civilization or colonization? Neurogastro-
enterol Motil 2005; 17 : 317-324 [PMID: 15916618]
19 Matricon J , Meleine M, Gelot A, Piche T, Dapoigny M, Mull -
er E, Ardid D. Review article: Associations between immune
activation, intestinal permeability and the irritable bowel
syndrome. Aliment Pharmacol Ther 2012; 36 : 1009-1031 [PMID:
23066886 DOI: 10.1111/apt.12080]
20
Spiller R
, Garsed K. Postinfectious irritable bowel syndrome.